Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Assessing Predictive Performance of Fibrosis-4 Index in Settings With Lower Prevalence of Liver Fibrosis.
Mary E Rinella, Michael R Charlton, Yestle Kim, Suneil Hosmane, Tom O'Connell
Published: 202510.1016/j.cgh.2025.12.014
Abstract
Clinical guidelines for screening for liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) commonly recommend use of the Fibrosis-4 (FIB-4) index as a first-line test, followed by subsequent testing and referral for FIB-…
Preview only. Read the full abstract at the source